ATE342081T1 - Aerosolinhalator - Google Patents

Aerosolinhalator

Info

Publication number: ATE342081T1
Authority: AT; Austria
Prior art keywords: hfa; actuator; aerosol inhaler; hydrofluoroalkane; heptafluoropropane
Prior art date: 2000-01-07

Application number

AT01900382T

Other languages

English (en)

Inventor

Gaetano Brambilla

Isabella Panza

Alessandra Ferraris

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-07

Filing date

2001-01-02

Publication date

2006-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11443627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE342081(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-02 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2006-11-15 Application granted granted Critical

2006-11-15 Publication of ATE342081T1 publication Critical patent/ATE342081T1/de

Links

239000000443 aerosol Substances 0.000 title abstract 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 abstract 2
LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
150000005828 hydrofluoroalkanes Chemical class 0.000 abstract 2
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 abstract 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
239000005642 Oleic acid Substances 0.000 abstract 1
239000002202 Polyethylene glycol Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000006184 cosolvent Substances 0.000 abstract 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
229920001223 polyethylene glycol Polymers 0.000 abstract 1
239000003380 propellant Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Nozzles (AREA)
Cosmetics (AREA)

AT01900382T 2000-01-07 2001-01-02 Aerosolinhalator ATE342081T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2000MI000010A IT1317720B1 (it)	2000-01-07	2000-01-07	Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.

Publications (1)

Publication Number	Publication Date
ATE342081T1 true ATE342081T1 (de)	2006-11-15

Family

ID=11443627

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01900382T ATE342081T1 (de)	2000-01-07	2001-01-02	Aerosolinhalator

Country Status (23)

Country	Link
US (1)	US20050034720A1 (de)
EP (1)	EP1244487B1 (de)
AT (1)	ATE342081T1 (de)
AU (1)	AU2512801A (de)
BR (1)	BR0107730B1 (de)
CA (1)	CA2396273C (de)
CZ (1)	CZ303394B6 (de)
DE (1)	DE60123746T2 (de)
DK (1)	DK1244487T3 (de)
DZ (1)	DZ3243A1 (de)
EG (1)	EG22790A (de)
ES (1)	ES2273800T3 (de)
HU (1)	HU229516B1 (de)
IT (1)	IT1317720B1 (de)
JO (1)	JO2506B1 (de)
MA (1)	MA26392A1 (de)
PL (1)	PL198683B1 (de)
PT (1)	PT1244487E (de)
SA (1)	SA01210645B1 (de)
SI (1)	SI1244487T1 (de)
SK (1)	SK286139B6 (de)
TN (1)	TNSN01003A1 (de)
WO (1)	WO2001049350A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010031244A1 (en) *	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
WO2003026559A2 (en) *	2001-09-28	2003-04-03	Kurve Technology, Inc	Nasal nebulizer
EP1340492A1 (de) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
US8122881B2 (en)	2002-05-09	2012-02-28	Kurve Technology, Inc.	Particle dispersion device for nasal delivery
US20070095342A1 (en) *	2005-10-18	2007-05-03	Bijan Olfati	Accessorized inhaler
EP2106268B1 (de)	2006-08-30	2018-12-12	Kurve Technology, Inc.	Vorrichtung zur erzeugung und abgabe eines aerosols
BRPI0603695A (pt) *	2006-09-13	2008-04-29	Cesar Eduardo Marques Da Silva	aerocámara para aplicação de medicamentos aerossol com válvula geométrica
ES2394589T3 (es)	2007-12-14	2013-02-04	Aerodesigns, Inc	Suministro de productos alimenticios transformables en aerosol
EP2080507A1 (de)	2008-01-15	2009-07-22	CHIESI FARMACEUTICI S.p.A.	Pharmazeutische Formulierungen mit einem anticholinergischen Arzneimittel
RS53514B1 (sr)	2009-10-02	2015-02-27	Chiesi Farmaceutici S.P.A.	Farmaceutske aerosolne formulacije od formoterola i beklometazon dipropionata
EP2512438B1 (de) *	2009-12-16	2017-01-25	3M Innovative Properties Company	Formulierungen und verfahren zur steuerung der mdi-partikelgrössenfreisetzung
KR20120106753A (ko)	2009-12-23	2012-09-26	키에시 파르마슈티시 엣스. 피. 에이.	Ｃｏｐｄ용 에어로졸 제제
PE20160853A1 (es)	2009-12-23	2016-09-14	Chiesi Farm Spa	Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc)
BR112012015334A2 (pt)	2009-12-23	2016-03-15	Chiesi Farma Spa	terapia combinada para doença pulmonar obstrutiva crônica
MX340264B (es)	2009-12-23	2016-07-04	Chiesi Farm Spa	Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica.
US9603906B2 (en)	2012-02-01	2017-03-28	Protalix Ltd.	Inhalable liquid formulations of DNase I
EP3421042B1 (de)	2012-03-07	2024-04-17	Beyond Air Ltd	Inhalation von stickoxid zur behandlung von atemwegserkrankungen
BR112016014583B1 (pt)	2013-12-30	2022-12-20	Chiesi Farmaceutici S.P.A	Composição de solução farmacêutica em aerossol, inalador pressurizado de dose calibrada e uso da dita composição
US10098837B2 (en)	2016-07-28	2018-10-16	Chiesi Farmaceutici S.P.A.	Combination therapy for COPD

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3361306A (en) *	1966-03-31	1968-01-02	Merck & Co Inc	Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) *	1969-12-10	1971-11-23	Schering Corp	Aerosol inhaler with flip-up nozzle
US4185100A (en) *	1976-05-13	1980-01-22	Johnson & Johnson	Topical anti-inflammatory drug therapy
US4499108A (en) *	1983-06-08	1985-02-12	Schering Corporation	Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) *	1983-12-24	1984-02-01	Tanabe Seiyaku Co	Carbostyril derivatives
IT1196142B (it) *	1984-06-11	1988-11-10	Sicor Spa	Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) *	1985-01-03	1986-04-22	David Rubin	Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) *	1985-05-22	1993-03-09	Liposome Technology, Inc.	Corticosteroid inhalation treatment method
US5225183A (en) *	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
IT1244441B (it) *	1990-09-13	1994-07-15	Chiesi Farma Spa	Dispositivo per l'inalazione boccale di farmaci aerosol
US6006745A (en) *	1990-12-21	1999-12-28	Minnesota Mining And Manufacturing Company	Device for delivering an aerosol
US5190029A (en) *	1991-02-14	1993-03-02	Virginia Commonwealth University	Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
ATE171630T1 (de) *	1991-05-21	1998-10-15	Abbott Lab	Aerosolinhalationsvorrichtung
SK24494A3 (en) *	1991-08-29	1994-09-07	Christoph Klein	Medicinal device for inhalation of dosed aerosols
DE4230876A1 (de) *	1992-03-17	1993-09-23	Asta Medica Ag	Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
EP0673240B1 (de) *	1992-12-09	1999-03-24	Boehringer Ingelheim Pharmaceuticals Inc.	Stabilisierte medizinische aerosollösungen
SE9203743D0 (sv) *	1992-12-11	1992-12-11	Astra Ab	Efficient use
US5899201A (en) *	1993-05-26	1999-05-04	Minnesota Mining And Manufacturing Company	Aerosol actuator
US5819730A (en) *	1993-06-09	1998-10-13	Glaxo Wellcome Australia Ltd.	Device for administering pharmaceutical substances
PT735884E (pt) *	1993-12-20	2000-09-29	Minnesota Mining & Mfg	Formulacoes de aerossol de flunisolida
US5508269A (en) *	1994-10-19	1996-04-16	Pathogenesis Corporation	Aminoglycoside formulation for aerosolization
US5653961A (en) *	1995-03-31	1997-08-05	Minnesota Mining And Manufacturing Company	Butixocort aerosol formulations in hydrofluorocarbon propellant
SI0820279T1 (en) *	1995-04-14	2002-12-31	Smithkline Beecham Corporation	Metered dose inhaler for albuterol
CA2218179A1 (en) *	1995-04-14	1996-10-17	Glaxo Wellcome Inc.	Metered dose inhaler for beclomethasone dipropionate
BR9604978A (pt) *	1995-04-14	1998-06-09	Glaxo Wellcome Inc	Inalador com dose medida
JPH11509434A (ja) *	1995-04-14	1999-08-24	グラクソ、ウェルカム、インコーポレーテッド	サルメテロール用計量投与用吸入器
WO1998003533A1 (en)	1996-07-24	1998-01-29	Oligos Etc. And Oligos Therapeutics, Inc.	Antisense oligonucleotides as antibacterial agents
US6413496B1 (en) *	1996-12-04	2002-07-02	Biogland Ireland (R&D) Limited	Pharmaceutical compositions and devices for their administration
DK1014943T3 (da) *	1997-02-05	2002-10-14	Jago Res Ag	Medicinske aerosolformuleringer
US6193954B1 (en) *	1997-03-21	2001-02-27	Abbott Laboratories	Formulations for pulmonary delivery of dopamine agonists
US5891419A (en) *	1997-04-21	1999-04-06	Aeropharm Technology Limited	Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) *	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
BR7702049U (pt) *	1997-09-05	1999-09-14	Chiesi Farma Spa	Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en) *	1997-10-17	1999-09-21	Systemic Pulmonary Development, Ltd.	Methods and apparatus for delivering aerosolized medication
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6045784A (en) *	1998-05-07	2000-04-04	The Procter & Gamble Company	Aerosol package compositions containing fluorinated hydrocarbon propellants
US6451285B2 (en) *	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) *	1998-06-26	2001-06-05	Elan Corporation Plc	Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
JP2000112547A (ja) *	1998-10-05	2000-04-21	Mitsubishi Electric Corp	基板電圧発生回路および半導体集積回路装置
DE19847969A1 (de) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Lagerfähig flüssige Formulierung mit Formoterol
DK1283036T3 (da) *	1998-11-13	2008-03-25	Jagotec Ag	Törpulver til inhalation
IT1303788B1 (it) *	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
US6004537A (en) *	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) *	1998-12-18	2001-09-18	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
CA2317999C (en) *	1999-09-11	2004-11-09	Glaxo Group Limited	Pharmaceutical formulation of fluticasone propionate
IT1317846B1 (it) *	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) *	2000-05-12	2003-08-27	Chiesi Farma Spa	Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
JP5392880B2 (ja) *	2000-05-22	2014-01-22	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	加圧式定量吸入器のための安定な製薬学的溶液製剤
DE60103527T2 (de) *	2001-07-02	2005-06-16	Chiesi Farmaceutici S.P.A.	Optimierte Tobramycin-Formulierung zur Aerosolbildung
US6616193B2 (en) *	2001-10-03	2003-09-09	Kool, L.L.C.	Ventilating system connector assembly and method of use
EP1415647A1 (de) *	2002-10-23	2004-05-06	CHIESI FARMACEUTICI S.p.A.	Langwirkende beta-2-Agonisten in ultrafeiner Formulierung
EP1340492A1 (de) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
IL163843A0 (en) *	2002-03-01	2005-12-18	Chiesi Farma Spa	Formoterol superfine formulation

2000
- 2000-01-07 IT IT2000MI000010A patent/IT1317720B1/it active
2001
- 2001-01-02 PL PL356849A patent/PL198683B1/pl unknown
- 2001-01-02 ES ES01900382T patent/ES2273800T3/es not_active Expired - Lifetime
- 2001-01-02 CZ CZ20022331A patent/CZ303394B6/cs not_active IP Right Cessation
- 2001-01-02 HU HU0300405A patent/HU229516B1/hu unknown
- 2001-01-02 DK DK01900382T patent/DK1244487T3/da active
- 2001-01-02 AT AT01900382T patent/ATE342081T1/de active
- 2001-01-02 PT PT01900382T patent/PT1244487E/pt unknown
- 2001-01-02 DE DE60123746T patent/DE60123746T2/de not_active Expired - Lifetime
- 2001-01-02 WO PCT/EP2001/000002 patent/WO2001049350A1/en not_active Ceased
- 2001-01-02 BR BRPI0107730-9A patent/BR0107730B1/pt active IP Right Grant
- 2001-01-02 EP EP01900382A patent/EP1244487B1/de not_active Expired - Lifetime
- 2001-01-02 CA CA002396273A patent/CA2396273C/en not_active Expired - Fee Related
- 2001-01-02 DZ DZ013243A patent/DZ3243A1/fr active
- 2001-01-02 SI SI200130673T patent/SI1244487T1/sl unknown
- 2001-01-02 SK SK948-2002A patent/SK286139B6/sk not_active IP Right Cessation
- 2001-01-02 US US10/168,546 patent/US20050034720A1/en not_active Abandoned
- 2001-01-02 AU AU25128/01A patent/AU2512801A/en not_active Abandoned
- 2001-01-05 TN TNTNSN01003A patent/TNSN01003A1/fr unknown
- 2001-01-06 EG EG20010009A patent/EG22790A/xx active
- 2001-01-10 SA SA01210645A patent/SA01210645B1/ar unknown
2002
- 2002-01-07 JO JO20016A patent/JO2506B1/en active
- 2002-06-25 MA MA26712A patent/MA26392A1/fr unknown

Also Published As

Publication number	Publication date
AU2512801A (en)	2001-07-16
HU229516B1 (en)	2014-01-28
DE60123746T2 (de)	2007-10-11
SI1244487T1 (sl)	2007-04-30
US20050034720A1 (en)	2005-02-17
IT1317720B1 (it)	2003-07-15
DK1244487T3 (da)	2007-02-19
BR0107730A (pt)	2003-02-25
EG22790A (en)	2003-08-31
HUP0300405A2 (hu)	2003-06-28
SK9482002A3 (en)	2002-10-08
PT1244487E (pt)	2007-01-31
DE60123746D1 (de)	2006-11-23
CA2396273C (en)	2009-11-17
TNSN01003A1 (fr)	2003-04-03
BR0107730B1 (pt)	2009-05-05
EP1244487A1 (de)	2002-10-02
EP1244487B1 (de)	2006-10-11
PL198683B1 (pl)	2008-07-31
HUP0300405A3 (en)	2003-07-28
CZ303394B6 (cs)	2012-08-29
ITMI20000010A1 (it)	2001-07-07
DZ3243A1 (fr)	2001-07-12
CA2396273A1 (en)	2001-07-12
JO2506B1 (en)	2009-10-05
ITMI20000010A0 (it)	2000-01-07
MA26392A1 (fr)	2004-12-01
SK286139B6 (sk)	2008-04-07
ES2273800T3 (es)	2007-05-16
CZ20022331A3 (cs)	2002-11-13
PL356849A1 (en)	2004-07-12
WO2001049350A1 (en)	2001-07-12
SA01210645B1 (ar)	2007-07-31

Legal Events

Date

Code

Title

Description

2007-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1244487

Country of ref document: EP

Publication	Publication Date	Title
DZ3243A1 (fr)	2001-07-12	Inhalateur aerosol
IT1317846B1 (it)	2003-07-15	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
CY1106904T1 (el)	2012-05-23	Φαρμακευτικη συνθεση αερολυματος περιεχουσα hfa 227 και hfa 134a
NO20010391D0 (no)	2001-01-23	Medisinske aerosolformuleringer
ATE128350T1 (de)	1995-10-15	Pharmazeutische aerosolformulierung.
MY119074A (en)	2005-03-31	Pharmaceutical aerosol composition
CA2445516A1 (en)	2002-11-21	Metered dose delivery device for liquid and powder agents
MXPA02011414A (es)	2003-06-06	Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis.
NO20030133D0 (no)	2003-01-10	Ny aerosolformulering inneholdende et polart fluorert molekyl
BG107257A (en)	2003-06-30	Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
EP2612703A3 (de)	2013-08-28	Partikelmaterialien
TH48089A (th)	2001-11-05	เครื่องสูดดมชนิดละอองลอย
YU87902A (sh)	2005-06-10	Stabilne farmaceutske formulacije rastvora za inhalatore odmerene doze pod pritiskom